Search Results

You are looking at 1 - 7 of 7 items for :

  • Clinical Pharmacy x
Clear All
Open access

Elena Belousova, Vladimir Sukhorukov, Marina Dorofeeva, Lev Shagam and Dmitrii V. Vlodavetz

-015-0359-5. Davydov E.V., Goode D.L., Sirota M., Cooper G.M., Sidow A., Batzoglou S.: Identifying a high fraction of the human genome to be under selective constraint using GERP++ . PLoS Comput. Biol., 2010, 6: e1001025. Della Sala G., Pizzorusso T.: Synaptic plasticity and signaling in Rett syndrome. Dev. Neurobiol., 2014, 74: 178–196. Dolce A., Ben-Zeev B., Naidu S., Kossoff E.H.: Rett syndrome and epilepsy: an update for child neurologists . Pediatr. Neurol., 2013, 48: 337–345. Gadalla K.K., Bailey M.E., Cobb S.R.: MeCP2 and Rett syndrome

Open access

Heinz Gregor Wieser

., 2005, 37: 733–738. El Helou J., Navarro V., Depienne C., Fedirko E., LeGuern E., Baulac M. et al.: K-complex induced seizures in autosomal dominant nocturnal frontal lobe epilepsy . Clin. Neurophysiol., 2008, 119: 2201–2204. Epi4K Consortium; Epilepsy Phenome/Genome Project, Allen A.S., Berkovic S.F., Cossette P., Delanty N., Dlugos D., Eichler E.E., Epstein M.P. et al.: De novo mutations in epileptic encephalopathies . Nature, 2013, 501: 217–221. EPICURE Consortium; EMINet Consortium, Steffens M., Leu C., Ruppert A.K., Zara F., Striano P

Open access

Katia S. Kovacheva, Zornica B. Kamburova, Savelina L. Popovska, Ivan N. Ivanov, Maria N. Simeonova and Petia N. Angelova

and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Insl 1998;90( 15): 1138-45. 11. Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer. 2004;4<9): 665-76. 12. Agnarsson BA, Jonasson JG, Bjomsdottir IB, Barkardottir RB, Egilsson V, Sigurdsson H. Inherited BRCA2 mutation associated with high grade breast cancer. Breast Cancer Res Treat. 1998;4 7(2): 121 -7. 13. National Human Genome research Institute [Internet]. Breast cancer information core Breast cancer, [cited 2013 Nov 2]. Available

Open access

Vesela D. Tomova, Tihomir R. Rashev and Milena A. Atanasova

;162(20):2345-7. 15. Thanassoulis G, Campbell CY, Owens DS, Smith JG, Smith AV, Peloso GM, et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med. 2013;368:503-12. 16. Psaty BM, O’Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI, et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009;2(l):73-80. 17. Gotoh T, Kuroda T, Yamasawa M, Nishinaga M, Mitsuhashi T, Seino

Open access

Vera E. Papochieva, Dimitrinka S. Miteva, Penka I. Perenovska and Guergana Petrova

pediatric disease. PLoS ONE 2012;7(4):e33891. 18. Cerri S, Spagnolo P, Luppi F, Richeldi L. Smoking-related interstitial lung disease. In: Cordier JF, editor. Orphan Lung Diseases: Volume 54 of European Respiratory Monograph. Plymouth: European Respiratory Society; 2011.376 p. 19. Strenger V, Urban C. Chromosomal integration of the HHV-6 genome as a possible cause of persistent HHV-6 detection in a patient with langerhans cell histiocytosis. Pathol Oncol Res. 2010; 16(1): 125-6. 20. Ribeiro KB, Degar B, Antoneli CB, Rollins

Open access

Regina S. Komsa-Penkova, Georgi M. Golemanov, Zdravka V. Radionova, Pencho T. Tonchev, Sergej D. Iliev and Veselin V. Penkov

;115:988-94. 66. Turk V, Stoka V, Vasiljeva O, Renko M, Sun T, Turk B, et al. Cysteinecathepsins: From structure, function and regulation to new frontiers. Biochim Biophys Acta. 2012;1824(1):68-88. 67. Rossi A, Deveraux Q, Turk B, Sali A. Comprehensive search for cysteine cathepsins in the human genome. Biol Chem. 2004;385:363- 72. 68. Hedrich J, Lottaz D, Meyer K, Yiallouros Ir, Jahnen-Dechent W, Stöcker Wr, et al. Fetuin-A and Cystatin C Are Endogenous Inhibitors of Human Meprin Metalloproteases. Biochemistry. 2010;49(39):8599-607. 69. Leite-Browning ML

Open access

Sonia Elena Popovici, Ovidiu Horea Bedreag and Dorel Sandesc

– Resistant Acientobacter baumannii in Intensive Care Units and Successful Outbreak Control Program. Journal of Korean Medical Science 2010;7:999-1004 7. Wright MS, Iovleva A, Jacobs MR, et al. Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment. Genome Med 2016;8(1):26. 8. Asif M, Alvi IA, Rehman SU. Insight to Acinetobacter baumannii:pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities 9. Peleg AY, Seifert H, Paterson D. Acinetobacter baumannii: Emergence of a